Influence of dosing pattern of antipsychotics on treatment outcome of delirium in patients with advanced cancer

Abstract Background Clinical guidelines recommend antipsychotics for the treatment of delirium; however, there has been no confirmed recommendation regarding their administrating patterns. This study aims to investigate whether different dosing patterns of antipsychotics (single or multiple administ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Japanese journal of clinical oncology 2023-03, Vol.53 (4), p.321-326
Hauptverfasser: Abe, Akiko, Fujisawa, Daisuke, Miyajima, Kaya, Takeuchi, Emi, Takeuchi, Mari, Mimura, Masaru, Imai, Kengo, Uemura, Keiichi, Watanabe, Hiroaki, Matsuo, Naoki, Matsuda, Yoshinobu, Maeda, Isseki, Ogawa, Asao, Yoshiuchi, Kazuhiro, Iwase, Satoru
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background Clinical guidelines recommend antipsychotics for the treatment of delirium; however, there has been no confirmed recommendation regarding their administrating patterns. This study aims to investigate whether different dosing patterns of antipsychotics (single or multiple administrations) influence the outcomes of delirium treatment. Methods This is a secondary analysis of a prospective observational study involving patients with advanced cancer and delirium receiving antipsychotics. The Delirium Rating Scale Revised-98 was administered at baseline and after 72 h of starting pharmacotherapy. Patients were classified into single administration group (received a single dosage within 24 h before the assessment) and multiple administration group (received more than one dosage). Results A total of 555 patients (single administration 492 (88.6%); multiple administration 63 (11.4%)) were subjected to analyses. The patients in the multiple administration group were more likely to be male, in psycho-oncology consulting settings, with lower performance status, with hyperactive delirium and with severer delirium symptoms. In the multivariate analysis, single administration was significantly associated with better improvement of delirium (p 
ISSN:1465-3621
1465-3621
DOI:10.1093/jjco/hyac205